<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02469220</url>
  </required_header>
  <id_info>
    <org_study_id>RHN_ALK_01</org_study_id>
    <nct_id>NCT02469220</nct_id>
  </id_info>
  <brief_title>Diet Treatment of Patients With Ulcerative Colitis in Remission</brief_title>
  <official_title>Diet Treatment of Patients With Ulcerative Colitis in Remission</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vendsyssel Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vendsyssel Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study examines the effect of a low FODMAP diet in patients with UC in remission but still
      having GI symptoms (IBS in IBD). 15 patients will be on watchful waiting. 15 patients will be
      on low FODMAP diet. 15 patients with recieve FODMAPs in their diet.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients are randomized to either standard care, low FODMAP diet or a normal FODMAP diet.
      Run-in on a low FODMAP diet, thereafter parallel design where one arm is assign a blinded
      food supplement with low FODMAP content and the other arm is assigned a blinded food
      supplement containing FODMAP. A control group is &quot;watchful waiting&quot;.

      Symptom reports, blood, and fecal samples are collected.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gastrointestinal symptoms</measure>
    <time_frame>Week 6</time_frame>
    <description>IBS-SSS questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Week 6</time_frame>
    <description>SF-36 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain diary</measure>
    <time_frame>Daily during the study</time_frame>
    <description>VAS scales on a daily basis</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>Low FODMAP diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diet with a low content of fermentable oligo-, di-, monosaccharides and polyols (low FODMAP diet). The patients will receive dietary instructions from registered clinical dieticians. A food supplement low in FODMAPS are administered in a blinded fashion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standardized FODMAP</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Diet with a low content of fermentable oligo-, di-, monosaccharides and polyols (low FODMAP diet). The patients will receive dietary instructions from registered clinical dieticians. A food supplement with FODMAPS are administered in a blinded fashion.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Watchful waiting. No diets or food supplements are administered</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Low FODMAP</intervention_name>
    <description>Blinded food supplements containing only items with a low content of FODMAPs</description>
    <arm_group_label>Low FODMAP diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Standardized FODMAP</intervention_name>
    <description>Blinded food supplements containing FODMAPs</description>
    <arm_group_label>Standardized FODMAP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Colitis ulcerosa in remission (calciprotectin&lt;200 and normal sigmoidoscopy)

          -  ROM IV criteria fullfilled

          -  Stable medical therapy

        Exclusion Criteria:

          -  Intake of a low FODMAP diet within the past 6 weeks prior to baseline

          -  Atypical colitis ulcerosa primarily right sided disease and calciprotectin &gt;50 unless
             normal sigmoidoscopy

          -  If diarrhea: Clostridium difficile infection

          -  Lactose intolerance

          -  Systemisk or local treatment for CU other than 5-aminosalicylicacid or biological
             therapy

          -  Antibiotics within 6 weeks

          -  Pregnancy

          -  Activity in UC

          -  Coeliac disease

          -  Abnormal transglutaminase

          -  Eating disorder

          -  Special diet preventing the low FODMAP diet

          -  Other GI disease or other disease explaining symptoms

          -  Medication intake explaining symptoms

          -  Not able to follow protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anne L Krarup, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>North Denmark Regional Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeanette Soerensen, PhD-student</last_name>
    <role>Principal Investigator</role>
    <affiliation>North Denmark Regional Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anne L Krarup, PhD</last_name>
    <phone>004597640770</phone>
    <email>apslk@rn.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jeanette Soerensen, PhD-student</last_name>
    <email>j.soerensen@rn.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>North Denmark Regional Hospital</name>
      <address>
        <city>Hj√∏rring</city>
        <state>Nordjylland</state>
        <zip>9800</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anne L Krarup, PhD</last_name>
      <email>apslk@rn.dk</email>
    </contact>
    <contact_backup>
      <last_name>Jeanette Soerensen, PhD-student</last_name>
      <email>j.soerensen@rn.dk</email>
    </contact_backup>
    <investigator>
      <last_name>Anne L Krarup, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jeanette Soerensen, PhD-student</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 8, 2015</study_first_submitted>
  <study_first_submitted_qc>June 10, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 11, 2015</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vendsyssel Hospital</investigator_affiliation>
    <investigator_full_name>Anne Lund Krarup</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Diet</keyword>
  <keyword>low FODMAP</keyword>
  <keyword>UC</keyword>
  <keyword>IBS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

